McGill, Silverstein, and Jasim publish new Washington Manual on endocrinology

In March, Janet B. McGill, MD, MA, FACE, FACP; Julie M. Silverstein, MD; and Sina Jasim, MD, MPH, of WashU Medicine’s Division of Endocrinology, Metabolism & Lipid Research, published the fifth edition of The Washington Manual Endocrinology Subspecialty Consult. This edition comprises 38 updated chapters written by fellows and faculty members from medicine and surgical […]

Jasim appointed Director of Endocrine Neoplasia Services 

Dr. Sina Jasim, MD, was appointed Director of Endocrine Neoplasia Services at WashU Medicine’s Division of Endocrinology, Metabolism, and Lipid Research in March 2025. Since joining the institution in 2017, Dr. Jasim has significantly advanced clinical care and educational initiatives related to thyroid disease and endocrine neoplasia. Her comprehensive patient care includes managing thyroid nodules […]

Litvin details current and emerging therapies in cystic fibrosis

In January, Marina Litvin, MD, an Associate Professor of Medicine at WashU Medicine’s Division of Endocrinology, Metabolism and Lipid Research, published an editorial titled “Metabolic Syndrome in the Post-ETI Era” in the Journal of Cystic Fibrosis. Cystic fibrosis (CF) is an autosomal recessive disease caused by defective cystic fibrosis transmembrane regulator channels which leads to […]